BRD2 and hyperandrogenism: The study of dehydroepiandrostenedione sulfate revealed that it was slightly higher than in the group without hyperandrogenism but remained within the reference values, which indicated the predominance of the ovarian genesis of hyperandrogenic symptoms in group I. In addition, the analysis of the ratio of LH/FSH revealed that this figure was significantly higher in the group of patients with hyperandrogenism than in group II.